share_log

BridgeBio Pharma | 8-K: BridgeBio Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update

SEC announcement ·  Feb 22 07:36
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more